OTTIMO PHARMA LIMITED
Get an alert when OTTIMO PHARMA LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£83M
-26.2% vs 2024
Net assets
£80M
-28.8% vs 2024
Employees
20
+400% highest in 4 filed years
Profit before tax
—
Period ending 2025-12-31
Net assets
4-year trend · vs Health Care median
Accounts
4-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | |
| Profit before tax | — | — | — | — | — | |
| Net profit | — | — | -£1,660,237 | -£35,346,914 | -2,029% | |
| Cash | £2,297,472 | £984,841 | £112,899,276 | £83,292,725 | -26.2% | |
| Total assets less current liabilities | — | — | £112,207,580 | £84,556,182 | -24.6% | |
| Net assets | £2,188,452 | £980,052 | £112,252,660 | £79,891,214 | -28.8% | |
| Equity | £2,188,452 | £980,052 | £112,252,660 | £79,891,214 | -28.8% | |
| Average employees | 4 | 4 | 4 | 20 | +400% | |
| Wages | — | — | — | — | — | |
| Directors' remuneration | — | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|
| Current ratio | — | — | 81.43x | 8.18x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- OTTIMO PHARMA LIMITED 2024-09-23 → present
- ULTRAHUMAN EIGHT LIMITED 2017-03-03 → 2024-09-23
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Frazier & Deeter (UK Audit) LLP.
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The company is engaged in research and development activities and is reliant upon funding from it's investors to meet its operational and working capital needs. The company's forecasts and projections, taking account of expected expenditure and future investment, show that the company should be able to continue these activities within the level of its available facilities for the foreseeable future.”
Group structure
- OTTIMO PHARMA LIMITED · parent
- Ottimo Pharma (US), Inc 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 5 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| AKKARAJU, Srinivas | Director | 2024-12-18 | Mar 1968 | American |
| CHIN, Mark David | Director | 2024-12-18 | Jan 1982 | American |
| DANSEY, Roger Delemere, Dr. | Director | 2025-03-17 | Apr 1956 | American |
| DE RUBERTIS, Francesco | Director | 2020-11-13 | Jan 1970 | Italian |
| EPSTEIN, David Robert | Director | 2024-10-07 | Jul 1961 | American |
| SABRY, James Henderson | Director | 2024-10-15 | Dec 1958 | American |
| THOMPSON, Peter Armstrong | Director | 2024-12-18 | Jul 1959 | American |
Show 5 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| THE CAMBRIDGE PARTNERSHIP LIMITED | Corporate Secretary | 2017-03-03 | 2017-07-28 |
| COLEMAN, James Edward, Dr | Director | 2017-03-03 | 2024-09-28 |
| EDWARDS, Jon | Director | 2017-04-06 | 2020-11-13 |
| FINLAY, William James Jonathan, Dr | Director | 2017-03-03 | 2024-12-18 |
| JOHNSON, Kevin Stuart, Dr | Director | 2017-04-06 | 2022-02-09 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Dr William James Jonathan Finlay | Individual | Shares 50–75%, Voting 50–75%, Appoints directors | 2017-03-03 | Ceased 2017-04-06 |
| Dr James Edward Coleman | Individual | Shares 25–50%, Voting 25–50% | 2017-03-03 | Ceased 2017-04-06 |
Filing timeline
Last 20 of 74 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-06-16 RESOLUTIONS Resolution
- 2025-03-25 RESOLUTIONS Resolution
- 2025-01-06 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-08 | AA | accounts | Accounts with accounts type group | |
| 2026-03-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-03-20 | RP01AP01 | officers | Replacement filing of director appointment with name | |
| 2026-02-26 | CH01 | officers | Change person director company with change date | |
| 2026-02-26 | CH01 | officers | Change person director company with change date | |
| 2026-02-26 | CH01 | officers | Change person director company with change date | |
| 2025-06-16 | RESOLUTIONS | resolution | Resolution | |
| 2025-05-16 | AAMD | accounts | Accounts amended with accounts type small | |
| 2025-05-13 | AA | accounts | Accounts with accounts type group | |
| 2025-05-06 | SH01 | capital | Capital allotment shares | |
| 2025-04-24 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-25 | RESOLUTIONS | resolution | Resolution | |
| 2025-03-04 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-02-26 | TM01 | officers | Termination director company with name termination date | |
| 2025-02-26 | AP01 | officers | Appoint person director company with name date | |
| 2025-02-24 | AP01 | officers | Appoint person director company with name date | |
| 2025-02-24 | AP01 | officers | Appoint person director company with name date | |
| 2025-02-24 | SH01 | capital | Capital allotment shares | |
| 2025-01-17 | SH08 | capital | Capital name of class of shares | |
| 2025-01-06 | MA | incorporation | Memorandum articles |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 3
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.